Aspirin/AIDS study
This article was originally published in The Tan Sheet
Executive Summary
Community Research Initiative on AIDS plans to conduct a study to examine whether aspirin plays a role in inhibiting HIV. The trial is expected to include 46 randomized, blinded, HIV- positive, asymptomatic people who will take either 1 g aspirin four times daily or acetaminophen as a control. The eight-week study will begin enrolling participants in August. CRIA is negotiating to obtain drug donations and funding for the study. CRIA estimates the cost of the study at about $ 80,000